thanks II, I didn’t go back and read the dates & designs etc. the main point I’m trying to make is from what I understand and have tried to piece together, zantrene has never been dosed in a way that will give the drug it’s best chance of success. This looks to be our biggest issue atm, how long is it going to take until we get in human data that proves we have a drug that’s effective at low doses and will big pharma understand?
as can be seen by the current sp, some investors aren’t going to wait around for the answers.
General Comments / Chat, page-7620
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.88 |
Change
0.115(6.52%) |
Mkt cap ! $312.5M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.91 | $1.78 | $434.2K | 234.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 355 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 4393 | 1 |
View Market Depth
| Last trade - 12.53pm 11/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |